final action
on 07 Dec 2024
Last Applicant/ Owned by
info@rejuvethera.com
Houston
TX
77002-8121
Serial Number
98564323 filed on 22nd May 2024
Registration Number
N/A
Correspondent Address
Houston, TX 77002-8121
United States
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory Read More
Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
N/A
N/A
Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of COPD, chronic bronchitis, mucus hypersecretion, emphysema, asthma, sleep apnea, pulmonary hypertension, idiopathic pulmonary fibrosis (IPF), and other diseases, disorders, and conditions affecting the lungs and airways; Pharmaceutical preparations for the treatment and prevention of pulmonology, immunology, oncology, infectious diseases, and degenerative diseases; Pharmaceutical preparations for the treatment of COPD, chronic bronchitis, mucus hypersecretion, emphysema, asthma, sleep apnea, pulmonary hypertension, idiopathic pulmonary fibrosis (IPF), and other diseases, disorders, and conditions affecting the lungs and airways; Pharmaceutical preparations for treating asthma; Pharmaceutical preparations for preventing, diagnosing, treating and managing cancer, fibrotic diseases, NASH, Crohn's Disease, osteoarthritis, viral infections, and hepatitis C; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
N/A
N/A
No 98564323
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
07th Dec 2024 | NON-FINAL ACTION WRITTEN |
07th Dec 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
07th Dec 2024 | NON-FINAL ACTION E-MAILED |
06th Dec 2024 | ASSIGNED TO EXAMINER |
27th Nov 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
22nd May 2024 | NEW APPLICATION ENTERED |